Dr Ibrahim Ozovehe Yisa – Executive Director, Results, Performance and Learning.
Dr. Yisa is a 1978 medical graduate of Ahmadu Bello University, Zaria. He is a Public Health Physician with MPH, Ibadan and a fellow of the National Post Graduate Medical College in the Faculty of Public Health. He also holds a Master’s degree in Epidemiology and Medical Statistics from the University of Ibadan. Dr Yisa began his medical career with the Nigerian Army Medical Corps where he serviced from January 1976, having been commissioned into the Army, while he was still in the Medical School. He retired in 2006, after 31 years of meritorious service and went into full practice as a public health physician. He served as a consultant to the National Primary Health Care Agency (NPI Programme) and the WHO as an EPI Consultant from 2004 to 2008. He also served as the Immunization Expert with the European Union Partnership to Reinforce Immunization Efficiency (EU-PRIME) Project in Nigeria from 2008-2009. The Project was implemented at the federal level and in 22 States, as well as the FCT. Dr Yisa was the Monitoring and Evaluation Advisor to the DfiD Flagship Programme in Nigeria, the Partnership for Transforming Health System in Nigeria, Phase II (PATHS2) from 2009 to 2014 and was implemented at the federal level and in five states in Nigeria.
While still retaining this position, he was also appointed as the Deputy National Programme Manager (Technical) for PATHS2 from 2014 – October 2016. From December 2016, he assumed the position of the National Team Leader for the European Union Support to Immunization Governance in Nigeria (EU-SIGN) Project, which was implemented at the national level and in 23 states and the FCT. He held this position till 29 August 2019, when the contract for the technical arm of the project ended. With a few publications to his credit, Dr Yisa has other skills in Economic Evaluation of health technologies, having had the requisite training in Health Economics at the University of York in the UK, from 2009 – 2014. He has significant experience in assessing Value for Money (VFM) for health care projects.